Non-Invasive Ultrasonic Description of Tumor Evolution

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2021 Sep 28

PMID 34572788

Authors

Jerome Griffon

Delphine Buffello

Alain Giron

S Lori Bridal

Michele Lamuraglia

Affiliations

Soon will be listed here.

Abstract

Purpose: There is a clinical need to better non-invasively characterize the tumor microenvironment in order to reveal evidence of early tumor response to therapy and to better understand therapeutic response. The goals of this work are first to compare the sensitivity to modifications occurring during tumor growth for measurements of tumor volume, immunohistochemistry parameters, and emerging ultrasound parameters (Shear Wave Elastography (SWE) and dynamic Contrast-Enhanced Ultrasound (CEUS)), and secondly, to study the link between the different parameters.

Methods: Five different groups of 9 to 10 BALB/c female mice with subcutaneous CT26 tumors were imaged using B-mode morphological imaging, SWE, and CEUS at different dates. Whole-slice immunohistological data stained for the nuclei, T lymphocytes, apoptosis, and vascular endothelium from these tumors were analyzed.

Results: Tumor volume and three CEUS parameters (Time to Peak, Wash-In Rate, and Wash-Out Rate) significantly changed over time. The immunohistological parameters, CEUS parameters, and SWE parameters showed intracorrelation. Four immunohistological parameters (the number of T lymphocytes per mm and its standard deviation, the percentage area of apoptosis, and the colocalization of apoptosis and vascular endothelium) were correlated with the CEUS parameters (Time to Peak, Wash-In Rate, Wash-Out Rate, and Mean Transit Time). The SWE parameters were not correlated with the CEUS parameters nor with the immunohistological parameters.

Conclusions: US imaging can provide additional information on tumoral changes. This could help to better explore the effect of therapies on tumor evolution, by studying the evolution of the parameters over time and by studying their correlations.

References

Lassau N, Bonastre J, Kind M, Vilgrain V, Lacroix J, Cuinet M . Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study. Invest Radiol. 2014; 49(12):794-800. PMC: 4222794. DOI: 10.1097/RLI.0000000000000085. View

Mamou J, Oelze M, OBrien Jr W, Zachary J . Identifying ultrasonic scattering sites from three-dimensional impedance maps. J Acoust Soc Am. 2005; 117(1):413-23. DOI: 10.1121/1.1810191. View

Wildeboer R, van Sloun R, Schalk S, Mannaerts C, van der Linden J, Huang P . Convective-Dispersion Modeling in 3D Contrast-Ultrasound Imaging for the Localization of Prostate Cancer. IEEE Trans Med Imaging. 2018; 37(12):2593-2602. DOI: 10.1109/TMI.2018.2843396. View

Wildeboer R, Van Sloun R, Postema A, Mannaerts C, Gayet M, Beerlage H . Accurate validation of ultrasound imaging of prostate cancer: a review of challenges in registration of imaging and histopathology. J Ultrasound. 2018; 21(3):197-207. PMC: 6113189. DOI: 10.1007/s40477-018-0311-8. View

Rajendran J, Krohn K . Imaging hypoxia and angiogenesis in tumors. Radiol Clin North Am. 2005; 43(1):169-87. DOI: 10.1016/j.rcl.2004.08.004. View

Erler J, Weaver V . Three-dimensional context regulation of metastasis. Clin Exp Metastasis. 2008; 26(1):35-49. PMC: 2648515. DOI: 10.1007/s10585-008-9209-8. View

Chammings F, Latorre-Ossa H, Le Frere-Belda M, Fitoussi V, Quibel T, Assayag F . Shear wave elastography of tumour growth in a human breast cancer model with pathological correlation. Eur Radiol. 2013; 23(8):2079-86. DOI: 10.1007/s00330-013-2828-8. View

Therasse P, Arbuck S, Eisenhauer E, Wanders J, Kaplan R, Rubinstein L . New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000; 92(3):205-16. DOI: 10.1093/jnci/92.3.205. View

Opacic T, Dencks S, Theek B, Piepenbrock M, Ackermann D, Rix A . Motion model ultrasound localization microscopy for preclinical and clinical multiparametric tumor characterization. Nat Commun. 2018; 9(1):1527. PMC: 5906644. DOI: 10.1038/s41467-018-03973-8. View

10.

Dizeux A, Payen T, Barrois G, Le Guillou Buffello D, Bridal S . Reproducibility of Contrast-Enhanced Ultrasound in Mice with Controlled Injection. Mol Imaging Biol. 2016; 18(5):651-8. DOI: 10.1007/s11307-016-0952-y. View

11.

Juge L, Doan B, Seguin J, Albuquerque M, Larrat B, Mignet N . Colon tumor growth and antivascular treatment in mice: complementary assessment with MR elastography and diffusion-weighted MR imaging. Radiology. 2012; 264(2):436-44. DOI: 10.1148/radiol.12111548. View

12.

Levental K, Yu H, Kass L, Lakins J, Egeblad M, Erler J . Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009; 139(5):891-906. PMC: 2788004. DOI: 10.1016/j.cell.2009.10.027. View

13.

Turco S, El Kaffas A, Zhou J, Lutz A, Wijkstra H, Willmann J . Pharmacokinetic Modeling of Targeted Ultrasound Contrast Agents for Quantitative Assessment of Anti-Angiogenic Therapy: a Longitudinal Case-Control Study in Colon Cancer. Mol Imaging Biol. 2018; 21(4):633-643. PMC: 6616210. DOI: 10.1007/s11307-018-1274-z. View

14.

Egeblad M, Nakasone E, Werb Z . Tumors as organs: complex tissues that interface with the entire organism. Dev Cell. 2010; 18(6):884-901. PMC: 2905377. DOI: 10.1016/j.devcel.2010.05.012. View

15.

Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2008; 45(2):228-47. DOI: 10.1016/j.ejca.2008.10.026. View

16.

Lamuraglia M, Barrois G, Le Guillou-Buffello D, Santin M, Kerbol A, Comperat E . Monitoring Dual VEGF Inhibition in Human Pancreatic Tumor Xenografts With Dynamic Contrast-Enhanced Ultrasound. Technol Cancer Res Treat. 2020; 19:1533033819886896. PMC: 7026814. DOI: 10.1177/1533033819886896. View

17.

Minchinton A, Tannock I . Drug penetration in solid tumours. Nat Rev Cancer. 2006; 6(8):583-92. DOI: 10.1038/nrc1893. View

18.

Shiina T, Nightingale K, Palmeri M, Hall T, Bamber J, Barr R . WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 1: basic principles and terminology. Ultrasound Med Biol. 2015; 41(5):1126-47. DOI: 10.1016/j.ultrasmedbio.2015.03.009. View

19.

Hudson J, Williams R, Tremblay-Darveau C, Sheeran P, Milot L, Bjarnason G . Dynamic contrast enhanced ultrasound for therapy monitoring. Eur J Radiol. 2015; 84(9):1650-7. DOI: 10.1016/j.ejrad.2015.05.013. View

20.

Gerlinger M, Rowan A, Horswell S, Math M, Larkin J, Endesfelder D . Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012; 366(10):883-892. PMC: 4878653. DOI: 10.1056/NEJMoa1113205. View